|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 21 to 40 of 90
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Yamamoto, Chiho; Miyoshi, Hideaki; Fujiwara, Yutaka; Kameda, Reina; Ichiyama, Mei; Nomoto, Hiroshi; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya | Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus | - | Endocrine Journal | - | Jan-2016 |
| article | Nomoto, Hiroshi; Miyoshi, Hideaki | The difference between SGLT2 and DPP-4 inhibitors on glucose fluctuation in patients with type 2 diabetes | - | British Journal of Research | - | 2017 |
| article | Tsuzuki, Atsushi; Fujioka, Yoichiro; Yoshida, Aiko; Kashiwagi, Sayaka; Amano, Maho; Hira, Tohru; Nakamura, Akinobu; Miyoshi, Hideaki; Atsumi, Tatsuya; Ohba, Yusuke | Direct visualization of glucagon-like peptide-1 secretion by fluorescent fusion proteins | - | Journal of diabetes investigation | - | Jul-2022 |
| article | Nomoto, Hiroshi; Miyoshi, Hideaki; Nakamura, Akinobu; Atsumi, Tatsuya; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin | Do DPP-4 inhibitors improve endotherial cell function? | - | Current Trends in Cardiology | - | 2017 |
| article | Kamoshima, Hikaru; Nomoto, Hiroshi; Yamashita, Kumiko; Takahashi, Yuka; Tsuchida, Kazuhisa; Kuwabara, Saki; Miya, Aika; Cho, Kyu Yong; Kameda, Hiraku; Nakamura, Akinobu; Atsumi, Tatsuya; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Ono, Yuri; Miyoshi, Hideaki | Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? | - | Endocrine journal | - | 28-Jan-2022 |
| article | Yanagiya, Shingo; Cho, Kyu Yong; Nakamura, Akinobu; Nomoto, Hiroshi; Kawamoto, Yasuyuki; Kawakubo, Kazumichi; Komatsu, Yoshito; Mitsuhashi, Tomoko; Miyoshi, Hideaki; Atsumi, Tatsuya | The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring | - | Internal medicine | - | 1-Sep-2018 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus : An open-label, prospective, randomized, parallel-group comparison trial | - | Diabetes, Obesity and Metabolism | - | Mar-2019 |
| article | Takahashi, Kiyohiko; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Kitao, Naoyuki; Omori, Kazuno; Yamamoto, Kohei; Cho, Kyu Yong; Terauchi, Yasuo; Atsumi, Tatsuya | Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages | - | Scientific reports | - | 1-May-2018 |
| article | Nomoto, Hiroshi; Kimachi, Kimihiko; Miyoshi, Hideaki; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Nagai, So; Kondo, Takuma; Atsumi, Tatsuya | Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose | - | Endocrine Journal | - | Apr-2017 |
| article | Kameda, Reina; Nomoto, Hiroshi; Cho, Kyu Yong; Kawata, Shinichiro; Omori, Kazuno; Takeuchi, Jun; Nagai, So; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study | - | BMJ Open | - | Feb-2020 |
| article | Nomoto, Hiroshi; Furusawa, Sho; Nakamura, Akinobu; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Sakuma, Ichiro; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Miya, Aika; Kameda, Hiraku; Cho, Kyu Yong; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes : protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 st | - | BMJ Open | - | May-2022 |
| article | Nomoto, Hiroshi; Oba-Yamamoto, Chiho; Takahashi, Yuka; Takeuchi, Jun; Nagai, So; Yokoyama, Hiroki; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Kameda, Hiraku; Cho, Kyu Yong; Nakamura, Akinobu; Atsumi, Tatsuya; Miyoshi, Hideaki | Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes : Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study) | - | Diabetes Therapy | - | Mar-2021 |
| article | Kitao, Naoyuki; Miyoshi, Hideaki; Furumoto, Tomoo; Ono, Kota; Nomoto, Hiroshi; Miya, Aika; Yamamoto, Chiho; Inoue, Atsushi; Tsuchida, Kenichi; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Nakamura, Akinobu; Atsumi, Tatsuya; SAIS Study Group | The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters : a randomized, controlled trial (Sapporo Athero-Incretin Study 3) | - | Cardiovascular diabetology | - | 10-Oct-2017 |
| article | Takahashi, Kiyohiko; Nakamura, Akinobu; Miyoshi, Hideaki; Nomoto, Hiroshi; Kameda, Hiraku; Cho, Kyu Yong; Nagai, So; Shimizu, Chikara; Taguri, Masataka; Terauchi, Yasuo; Atsumi, Tatsuya | Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism | - | Endocrine Journal | - | Apr-2017 |
| article | Yamauchi, Yuki; Nakamura, Akinobu; Takahashi, Kiyohiko; Takase, Takahiro; Yamamoto, Chiho; Yokota, Isao; Atsumi, Tatsuya; Miyoshi, Hideaki | Factors with remission of fatty liver in patients With type 2 diabetes treated with ipragliflozin | - | Endocrine journal | - | 2019 |
| article (author version) | Chiba, Koki; Kameda, Hiraku; Miya, Aika; Nomoto, Hiroshi; Cho, Kyu Yong; Nakamura, Akinobu; Jin, Shigeki; Matoba, Kotaro; Miyoshi, Hideaki; Atsumi, Tatsuya | False Hypercortisolemia Due to Abnormal Albumin-Cortisol Binding in a Patient with Familial Dysalbuminemic Hyperthyroxinemia | - | Thyroid | - | 10-Feb-2022 |
| article | Cho, Kyu Yong; Nakamura, Akinobu; Omori, Kazuno; Takase, Takahiro; Miya, Aika; Yamamoto, Kohei; Nomoto, Hiroshi; Kameda, Hiraku; Taneda, Shinji; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone | - | Journal of Diabetes Investigation | - | 8-Jul-2021 |
| article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study) | - | Diabetes, Obesity and Metabolism | - | Mar-2020 |
| article | Shen, Wen-Jun; Patel, Shailja; Miyoshi, Hideaki; Greenberg, Andrew S.; Kraemer, Fredric B. | Functional interaction of hormone-sensitive lipase and perilipin in lipolysis | - | Journal of lipid research | - | Nov-2009 |
| article | Miya, Aika; Nakamura, Akinobu; Kameda, Hiraku; Nozu, Kandai; Miyoshi, Hideaki; Atsumi, Tatsuya | Gitelmanʼs syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration | - | Medicine | - | 2019 |
Showing results 21 to 40 of 90
|
